BioTrends Research Group Releases Non-Small-Cell Lung Cancer Report Findings
One hundred and five US-based medical oncologists were surveyed about their current and expected treatment patterns in one of the largest oncology indications.
Read MorePosted by Clinical Lab Products | Apr 24, 2012 | Cancer, Miscellaneous, Pancreatic |
One hundred and five US-based medical oncologists were surveyed about their current and expected treatment patterns in one of the largest oncology indications.
Read MorePosted by Clinical Lab Products | Apr 20, 2012 | Cancer, Miscellaneous |
The VeriStrat retrospective analysis was performed on serum samples from advanced non-squamous non-small cell lung cancer patients treated with the combination therapy bevacizumab plus erlotinib.
Read MorePosted by Clinical Lab Products | Sep 19, 2011 | Cancer, Miscellaneous |
The rates of new lung cancer cases in the US dropped among men in 35 states and among women in 6 states between 1999 and 2008.
Read MorePosted by Clinical Lab Products | Aug 16, 2010 | Cancer, Miscellaneous |
Research and Markets has announced the addition of the “The Top 20 Developers of Molecular Diagnostic Tests for Lung Cancer” report to their offering.
Read MorePosted by Clinical Lab Products | Aug 9, 2010 | Cancer, Miscellaneous |
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read More